AI model Claude discovers CRISPR-like enzyme system, Anthropic says
Key Points:
- AI company Anthropic announced that its AI model, Claude, autonomously discovered a new enzyme system in bacterial DNA that may represent a novel gene editing mechanism similar to CRISPR.
- The discovery was made after Claude analyzed a large DNA sequence database for 21 hours, identifying a system with characteristics and patterns reminiscent of CRISPR, which is known for its revolutionary genome-editing capabilities.
- Anthropic CEO Dario Amodei expressed optimism about AI-driven biological discoveries potentially leading to medical breakthroughs, while experts like Stanford’s Stanley Qi praised the AI’s ability to detect complex biological patterns rapidly.
- Some scientists, including microbiologist Kevin Blake, remain skeptical, cautioning that the newly identified system is not yet proven to rival CRISPR technology or have practical therapeutic applications.
- CRISPR technology, pioneered by Nobel laureates Emmanuelle Charpentier and Jennifer Doudna, has already enabled significant medical advances, including a recent successful gene-editing therapy for a rare metabolic disease in an infant.